Crossmark

Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells

Crossref DOI link: https://doi.org/10.1038/s41598-025-86874-3

Published Online: 2025-01-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Colakoglu Bergel, Ceyda https://orcid.org/0000-0002-7471-5071
Eryilmaz, Isil Ezgi https://orcid.org/0000-0002-3316-316X
Cecener, Gulsah https://orcid.org/0000-0002-3820-424X
Egeli, Unal https://orcid.org/0000-0001-7904-883X
Funding

Funding for this research was provided by:

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (222S648)

Bursa Uludag University, coordinatorship of scientific research (TGA-2022-1086)
License Information

Text and Data Mining valid from 2025-01-18

Version of Record valid from 2025-01-18
More Information

Article History

Received: 23 November 2024

Accepted: 14 January 2025

First Online: 18 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below